Mark Perrin

2014

In 2014, Mark Perrin earned a total compensation of $5.4M as Chief Executive Officer and Chairman of the Board at InVivo Therapeutics Holdings.

Compensation breakdown

Non-Equity Incentive Plan$140,000
Option Awards$4,628,496
Salary$392,308
Stock Awards$60,000
Other$161,557
Total$5,382,361

Perrin received $4.6M in option awards, accounting for 86% of the total pay in 2014.

Perrin also received $140K in non-equity incentive plan, $392.3K in salary, $60K in stock awards and $161.6K in other compensation.

Rankings

In 2014, Mark Perrin's compensation ranked 1,405th out of 13,032 executives tracked by ExecPay. In other words, Perrin earned more than 89.2% of executives.

ClassificationRankingPercentile
All
1,405
out of 13,032
89th
Division
Manufacturing
506
out of 4,966
90th
Major group
Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks
61
out of 736
92nd
Industry group
Surgical, Medical, And Dental Instruments And Supplies
30
out of 446
93rd
Industry
Surgical and Medical Instruments and Apparatus
16
out of 275
94th
Source: SEC filing on April 25, 2017.

Perrin's colleagues

We found four more compensation records of executives who worked with Mark Perrin at InVivo Therapeutics Holdings in 2014.

2014

Thomas Ulich

InVivo Therapeutics Holdings

Chief Scientific Officer

2014

Tamara Joseph

InVivo Therapeutics Holdings

General Counsel

2014

Steven McAllister

InVivo Therapeutics Holdings

Chief Financial Officer

2014

Michael Astrue

InVivo Therapeutics Holdings

Chief Executive Officer

In-depth

You may also like